Cardiovascular Regeneration and Stem Cell Therapeutics

Cardiovascular regeneration and stem cell therapeutics focus on repairing damaged heart tissue and restoring cardiac function following injury or disease. Various stem cell types, including mesenchymal stem cells, cardiac progenitor cells, and induced pluripotent stem cells (iPSCs), are being investigated for cardiac repair. These therapies aim to promote angiogenesis, reduce inflammation, regenerate cardiomyocytes, and improve heart function after myocardial infarction and heart failure. Advances in tissue engineering, biomaterials, and bioengineered cardiac patches are enhancing the effectiveness of regenerative therapies. Cell-based treatments are also being combined with gene editing and growth factor delivery to improve therapeutic outcomes. Ongoing clinical trials continue to evaluate the safety, efficacy, and long-term benefits of stem cell-based cardiovascular therapies. Researchers are addressing challenges such as cell survival, engraftment, immune compatibility, and scalable manufacturing for clinical use. Overall, cardiovascular regeneration represents a promising approach for reducing the burden of heart disease and advancing next-generation regenerative medicine.

    Related Conference of Cardiovascular Regeneration and Stem Cell Therapeutics

    September 24-25, 2026

    7th Annual summit on Cell Signaling and Cancer Therapy

    Paris, France

    Cardiovascular Regeneration and Stem Cell Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in